Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya

NCT01899820 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

2100

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Artemether lumefantrine
DRUG: Dihydroartemisinin piperaquine

Sponsor

Sabah Ahmed Omar

Collaborators

[object Object]
[object Object]